1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Mupirocin |
| brand | String | Bactroban, Centany |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Topical_antibiotics|Topical antibiotic]] • [[:Category:Antibacterials|Antibacterial]] |
| mechanism | String | '"`UNIQ--vote-000009FD-QINU`"' Active against gram-positive cocci including MRSA; the unique target underlies the absence of cross-resistance with other antibiotic classes. High-level resistance (plasmid-mediated mupA) is rising and limits prolonged or repeated use'"`UNIQ--ref-000009FE-QINU`"'. |
| uses | String | '"`UNIQ--vote-000009FF-QINU`"', '"`UNIQ--vote-00000A00-QINU`"', '"`UNIQ--vote-00000A01-QINU`"' |
| starting_dose | String | Topical: apply small amount to affected area TID × 5-10 days; nasal: apply half the contents of a single-use tube into each nostril BID × 5 days |
| preparations | String | 2% ointment; 2% cream; 2% nasal ointment (Bactroban Nasal) |
| fda_max | String | Limit topical to 10-day courses to reduce resistance pressure |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical • intranasal |
| onset | String | Days |
| duration | String | Hours per application |
| halflife | String | Not meaningfully described for topical use'"`UNIQ--ref-00000A02-QINU`"' |
| bioavailability | String | Topical; minimal systemic absorption'"`UNIQ--ref-00000A03-QINU`"' |
| pregnancy | String | Generally considered safe; minimal systemic exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
